Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2005 2
2006 5
2007 11
2008 7
2009 7
2010 6
2011 4
2012 6
2013 12
2014 4
2015 9
2016 10
2017 6
2018 6
2019 4
2020 5
2021 8
2022 11
2023 11
2024 8
2025 9
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148 results

Results by year

Filters applied: . Clear all
Page 1
Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents.
Lee SJ, Yu HT, Lee YJ, Lee SH, Heo JH, Ahn SG, Shin S, Doh JH, Her AY, Cho BR, Kim GS, Kwon TG, Lim SW, Shim J, Jang JY, Lee K, Cho YH, Choi CU, Lee SR, Park HB, Lee HC, Kim S, Yun KH, Ahn JH, Lee BK, Cho DK, Kim SY, Kim U, Kang TS, Choi SH, Kim WH, Lee JB, Rhee MY, Kim JB, Jo SH, Hyun DW, Kim D, Kim TH, Hong SJ, Uhm JS, Shin DH, Ahn CM, Kim BK, Joung B, Ko YG, Choi D, Hong MK, Jang Y, Pak HN, Kim JS; ADAPT AF-DES Investigators. Lee SJ, et al. Among authors: lee sr. N Engl J Med. 2026 Feb 12;394(7):658-668. doi: 10.1056/NEJMoa2512091. Epub 2025 Nov 8. N Engl J Med. 2026. PMID: 41211917 Clinical Trial.
Discontinuation of Beta-Blocker Therapy after Myocardial Infarction.
Choi KH, Kang D, Kim W, Doh JH, Kim J, Park YH, Ahn SG, Park JP, Kim SM, Cho BR, Nam CW, Cho JH, Joo SJ, Suh J, Jeong JO, Jang WJ, Goh CW, Yoon CH, Hwang JY, Lim SH, Lee SR, Shin ES, Kim BJ, Yu CW, Her SH, Kim HK, Park KT, Kim J, Kim J, Park TK, Lee JM, Cho J, Yang JH, Song YB, Choi SH, Gwon HC, Guallar E, Hahn JY; SMART-DECISION Investigators. Choi KH, et al. Among authors: lee sr. N Engl J Med. 2026 Apr 2;394(13):1302-1312. doi: 10.1056/NEJMoa2601005. Epub 2026 Mar 30. N Engl J Med. 2026. PMID: 41910427 Clinical Trial.
Efficacy and safety of low-dose atorvastatin plus ezetimibe for primary hypercholesterolemia: A randomized, double-blind, multicenter phase 3 trial.
Kim TO, Lee K, Cho JM, Yoon HJ, Park TH, Choi JH, Suh JW, Kim SY, Lim HS, Park JS, Cho DK, Park GM, Ahn SG, Shin S, Kwon SU, Kim DH, Lee SR, Sung JH, Park HC, Lee SW. Kim TO, et al. Among authors: lee sr. Lipids. 2025 Sep;60(5):317-326. doi: 10.1002/lipd.12442. Epub 2025 Apr 18. Lipids. 2025. PMID: 40251695 Free PMC article. Clinical Trial.
Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION-STEMI): a multicentre, non-inferiority, open-label, randomised trial.
Kim MC, Ahn JH, Hyun DY, Lim Y, Cho KH, Lee SH, Park S, Oh S, Sim DS, Hong YJ, Kim JH, Jeong MH, Cho JH, Lee SR, Kang DO, Hwang JY, Youn YJ, Lee JH, Jeong YH, Ahn JH, Kim DB, Choo EH, Kim CJ, Kim W, Rhew JY, Park JI, Yoo SY, Ahn Y; OPTION–STEMI Investigators. Kim MC, et al. Among authors: lee sr. Lancet. 2025 Sep 6;406(10507):1032-1043. doi: 10.1016/S0140-6736(25)01529-6. Epub 2025 Aug 31. Lancet. 2025. PMID: 40902612 Clinical Trial.
Discontinuation of β-blocker therapy in stabilised patients after acute myocardial infarction (SMART-DECISION): rationale and design of the randomised controlled trial.
Choi KH, Kim J, Kang D, Doh JH, Kim J, Park YH, Ahn SG, Kim W, Park JP, Kim SM, Cho BR, Nam CW, Cho JH, Joo SJ, Suh J, Jeong JO, Jang W, Yoon CH, Hwang JY, Lim SH, Lee SR, Shin ES, Kim BJ, Yu CW, Her SH, Kim HK, Park KT, Kim J, Park TK, Lee JM, Cho J, Yang JH, Song YB, Choi SH, Gwon HC, Guallar E, Hahn JY; SMART-DECISION investigators. Choi KH, et al. Among authors: lee sr. BMJ Open. 2024 Aug 31;14(8):e086971. doi: 10.1136/bmjopen-2024-086971. BMJ Open. 2024. PMID: 39645270 Free PMC article.
Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trial.
Kang J, Park KW, Han JK, Hwang D, Yang HM, Park S, Ahn HS, Hwang KK, Kim BG, Jeong JO, Ahn JH, Rhew JY, Park H, Kang TS, Koh JS, Park KT, Bang DW, Goh CW, Yoon HJ, Jo SH, Jang JY, Choi YJ, Lee SR, Lim YH, Kim HS; HOST-BR investigators. Kang J, et al. Among authors: lee sr. Lancet. 2025 Nov 8;406(10516):2244-2256. doi: 10.1016/S0140-6736(25)01571-5. Epub 2025 Oct 23. Lancet. 2025. PMID: 41631724 Clinical Trial.
Brucellar spondylitis.
Lee HJ, Hur JW, Lee JW, Lee SR. Lee HJ, et al. Among authors: lee sr. J Korean Neurosurg Soc. 2008 Oct;44(4):277-9. doi: 10.3340/jkns.2008.44.4.277. Epub 2008 Oct 30. J Korean Neurosurg Soc. 2008. PMID: 19096693 Free PMC article.
148 results